NEOSTIGMINE

​

Neostigmine is an important drug in the field of anesthesia, primarily due to its role in reversing the effects of non-depolarizing neuromuscular blocking agents (NMBAs). NMBAs are often administered during surgery to facilitate muscle relaxation, prevent patient movement, and provide optimal conditions for the surgical procedure. However, it is crucial to reverse the effects of NMBAs at the end of surgery to ensure the patient's safe recovery. This is where neostigmine plays a significant role. Some key reasons for its importance include:

​

1. Reversal of neuromuscular blockade: Neostigmine is an acetylcholinesterase inhibitor, which means it inhibits the enzyme responsible for breaking down acetylcholine. By increasing the concentration of acetylcholine at the neuromuscular junction, neostigmine effectively reverses the effects of non-depolarizing NMBAs, allowing the patient to regain normal muscle function.

2. Prevention of residual neuromuscular blockade: Residual neuromuscular blockade can lead to complications such as muscle weakness, respiratory insufficiency, and an increased risk of postoperative pulmonary complications. Neostigmine, when used appropriately, can prevent these complications by ensuring a complete reversal of the neuromuscular blockade.

3. Established safety and efficacy profile: Neostigmine has been used in anesthesia for many decades, and its safety and efficacy are well-established. When administered in appropriate doses and with the correct timing, it effectively reverses neuromuscular blockade with minimal side effects.

4. Cost-effective: Neostigmine is relatively inexpensive compared to other neuromuscular reversal agents, such as sugammadex, which can be important in resource-limited settings.

​​

​

Here are the main steps in neostigmine's mechanism of action:

​

1. Inhibition of acetylcholinesterase: Neostigmine binds to the active site of the acetylcholinesterase enzyme, which is responsible for hydrolyzing acetylcholine into choline and acetic acid. This competitive inhibition prevents the breakdown of acetylcholine at cholinergic synapses.

2. Increased acetylcholine levels: By inhibiting acetylcholinesterase, neostigmine increases the concentration of acetylcholine in the synaptic cleft, prolonging its availability and enhancing its interaction with both nicotinic and muscarinic acetylcholine receptors.

3. Reversal of neuromuscular blockade: In the context of anesthesia, neostigmine is used to reverse the effects of non-depolarizing neuromuscular blocking agents. The increased concentration of acetylcholine in the synaptic cleft competes with these agents for binding to the nicotinic acetylcholine receptors at the neuromuscular junction, eventually restoring normal neuromuscular transmission and muscle function.​

​

​

                                                                                         Key points about Neostigmine

​

• Most common anticholinesterase agent used.

 

• Quaternary amine that is poorly lipid soluble.

 

• It cannot cross the blood brain barrier.

 

• Anticholinesterase agent that reversibly binds and inactivates acetylcholinesterase, which increases the amount of acetylcholine at the neuromuscular junction and antagonizes nondepolarizing neuromuscular blockers.

 

• Principal site of action is postsynaptic.

 

• Used for antagonism of neuromuscular blockade.

 

• Used in conjunction with anticholinergic such as Glycopyrrolate.

 

• More than 50% is excreted unchanged in urine.

 

• As a cholinesterase inhibitor, can cause side effects related to increased cholinergic activity, such as bradycardia, increased secretions, bronchoconstriction, diarrhea, and muscle fasciculations.

​

​​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

​​

​​